Integrase Inhibitors Use and Cytomegalovirus Infection Predict Immune Recovery in People Living With HIV Starting First-Line Therapy-Reference-Cited by-同舟云学术

Integrase Inhibitors Use and Cytomegalovirus Infection Predict Immune Recovery in People Living With HIV Starting First-Line Therapy

Published:2021-01-01 Issue:1 Volume:86 Page:119-127
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Fabbiani Massimiliano,Borghetti Alberto,Squillace Nicola,Colafigli Manuela,Taramasso Lucia,Lombardi Andrea,Rossetti Barbara,Ciccullo Arturo,Colella Elisa,Picarelli Chiara,Berruti Marco,Latini Alessandra,Montagnani Francesca,Sambo Margherita,Di Biagio Antonio,Gori Andrea,Di Giambenedetto Simona,Bandera Alessandra

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference42 articles.

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection;Palella;N Engl J Med.,1998

2. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection;Mellors;Ann Intern Med.,1997

3. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies;Egger;Lancet.,2002

4. Serious fatal and nonfatal non-AIDS-defining illnesses in Europe;Mocroft;J Acquir Immune Defic Syndr.,2010

5. T-cell subset distribution in HIV-1-infected patients after 12 years of treatment-induced viremic suppression;Rönsholt;J Acquir Immune Defic Syndr.,2012

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Mechanism of HIV-1 Immune Reconstitution Failure: Understanding Lymphocyte Subpopulations and Interventions for Immunological Nonresponders;The Journal of Immunology;2024-06-01

2. Cytomegalovirus infection among people living with HIV in Sweden: Case profiles, treatment strategies and patient outcomes at Karolinska University Hospital 2010–2020;HIV Medicine;2024-02-13

3. Longitudinal Immunogenicity Study of SARS-CoV-2 mRNA Vaccines Across Subjects with Different Immunocompromising Conditions: Heterogeneity in the Immune Response and Crucial Role of the Booster Dose;2024

4. Genetic, virological, infectious, and pharmacological risk factors for CD4<sup>+</sup> T-cell regeneration failure in HIV-infected subjects receiving ART;HIV Infection and Immunosuppressive Disorders;2023-10-21

5. Pillars of long-term antiretroviral therapy success;Pharmacological Research;2023-10